Enhanced Topical Psoralen-UV-A Therapy via Targeting to Hair Follicles.
The renewed interest in Psoralen-UV-A (PUVA) therapy driven by impressive recent results in this field encourages the researchers and clinicians to shift the momentum back in its favor.1-3 As far as administration of low-cumulative UV-A doses minimizes the negative risks, the search for efficient modalities decreasing the frequency of sessions may help not to lose such therapeutic option.